Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04967248
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2021-07-08
Brief Title:
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women and Men With HRHER2- Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation After Disease Progression Following Endocrine Therapy as Monotherapy in the Real-world Setting
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-19
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-08
First Submit QC Date:
July 8 2021
Study First Post Date:
2021-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL